Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Sipuleucel-T (Provenge®) for castration-resistant prostate cancer.

Authors
  • Di Lorenzo, Giuseppe
  • Ferro, Matteo
  • Buonerba, Carlo
Type
Published Article
Journal
British Journal of Urology
Publisher
Wiley (Blackwell Publishing)
Publication Date
Jul 01, 2012
Volume
110
Issue
2 Pt 2
Identifiers
DOI: 10.1111/j.1464-410X.2011.10790.x
PMID: 22177289
Source
Medline
License
Unknown

Abstract

Sipuleucel-T is an effective treatment for prostate cancer, although its widespread use is uncertain for complex social and economic reasons.

Report this publication

Statistics

Seen <100 times